DRUG ALERTS & UPDATES
EMPLOYEE BENEFIT NEWS
Advisor Connect: Your resource center for better outcomes
EmpiRx Health realizes the important role advisors play in optimizing plan performance. Our consultative and collaborative approach empowers benefit advisors with actionable information and tools to educate clients on lowering overall pharmacy costs. Our mission is 100% focused on achieving mutual business growth, superior results, overall satisfaction and lasting partnerships through integrity, trust and respect..
We created an easy to use Advisor Toolkit that provides valuable information to help better manage today’s complex pharmacy benefits and reduce annual drug costs. Use this tool to inform your clients and set a plan of action.
Partner with us:
And as we expand our services to our advisors look for these programs coming soon:
- Loyalty Program
- Advisory Panel
- Producer Incentives
- News and Resources
TOOLS & DOWNLOADS
On June 28, 2016, FDA approved Gilead’s new drug, Epclusa, to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For patients with moderate to severe cirrhosis (decompensated cirrhosis), Epclusa is approved for use in combination with the drug ribavirin.read more